Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

Clinical trial NCT01569828 · COMPLETED

Trial details

NCT number: NCT01569828
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pharmacokinetics Renal Impaired Healthy Volunteer

Start date: 2009-03-01
Primary completion: 2009-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.